0001209191-23-027283.txt : 20230504
0001209191-23-027283.hdr.sgml : 20230504
20230504143047
ACCESSION NUMBER: 0001209191-23-027283
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230503
FILED AS OF DATE: 20230504
DATE AS OF CHANGE: 20230504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LILLY ENDOWMENT INC
CENTRAL INDEX KEY: 0000316011
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06351
FILM NUMBER: 23887977
BUSINESS ADDRESS:
STREET 1: 2801 NORTH MERIDIAN STREET
CITY: INDIANANAPOLIS
STATE: IN
ZIP: 46208
BUSINESS PHONE: 3179245471
MAIL ADDRESS:
STREET 1: 2801 NORTH MERIDIAN ST
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELI LILLY & Co
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 350470950
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
FORMER COMPANY:
FORMER CONFORMED NAME: LILLY ELI & CO
DATE OF NAME CHANGE: 19941024
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-03
0
0000059478
ELI LILLY & Co
LLY
0000316011
LILLY ENDOWMENT INC
2801 NORTH MERIDIAN STREET
INDIANAPOLIS
IN
46208-0068
0
0
1
0
0
Common Stock
2023-05-03
4
S
0
400
415.715
D
101866712
D
Common Stock
2023-05-03
4
S
0
2750
417.126
D
101863962
D
Common Stock
2023-05-03
4
S
0
3200
418.548
D
101860762
D
Common Stock
2023-05-03
4
S
0
6400
419.77
D
101854362
D
Common Stock
2023-05-03
4
S
0
9226
420.604
D
101845136
D
Common Stock
2023-05-03
4
S
0
19684
421.65
D
101825452
D
Common Stock
2023-05-03
4
S
0
19630
422.662
D
101805822
D
Common Stock
2023-05-03
4
S
0
12829
423.685
D
101792993
D
Common Stock
2023-05-03
4
S
0
6248
424.424
D
101786745
D
Common Stock
2023-05-03
4
S
0
4147
425.77
D
101782598
D
Common Stock
2023-05-03
4
S
0
1900
426.506
D
101780698
D
Common Stock
2023-05-03
4
S
0
6050
427.841
D
101774648
D
Common Stock
2023-05-03
4
S
0
14500
428.692
D
101760148
D
Common Stock
2023-05-03
4
S
0
17648
429.72
D
101742500
D
Common Stock
2023-05-03
4
S
0
30817
430.725
D
101711683
D
Common Stock
2023-05-03
4
S
0
13507
431.856
D
101698176
D
Common Stock
2023-05-03
4
S
0
7866
432.728
D
101690310
D
Common Stock
2023-05-03
4
S
0
1500
433.561
D
101688810
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $415.425 to $416.065, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), and (18) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $416.67 to $417.595, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $417.93 to $418.90, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $419.08 to $420.065, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $420.105 to $421.10, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $421.105 to $422.10, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $422.11 to $423.10, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $423.11 to $424.105, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $424.115 to $425.06, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $425.16 to $426.15, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $426.16 to $426.86, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $427.245 to $428.24, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $428.245 to $429.23, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $429.245 to $430.23, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $430.25 to $431.2425, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $431.25 to $432.24, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $432.26 to $433.20, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $433.29 to $434.00, inclusive.
/s/Diane M. Stenson, Vice President & Treasurer, on behalf of Lilly Endowment Inc.
2023-05-04